Risk Stratification for the Intensive Care Unit Following Pancreaticoduodenectomy

Abstract

Introduction In view of the limited capacities in intensive care units and the increasing economic burden, identification of risk factors could allow better and more efficient planning. Therefore, the aim of this study was to assess independent risk factors for the duration of intensive care unit stay after pancreatoduodenectomy (PD).

Methods 147 patients who underwent pancreatoduodenectomy in the time period from 2013 to 2015 were identified from a prospective database and a retrospective analysis was performed. The primary endpoint was length of time spent in the ICU. A retrograde analysis was performed using univariate and multivariate regression analysis. All pre-, intra- and postoperative parameters were considered in the analysis.

Results The median time spent in the intensive care unit (ICU) is one day. The univariate analysis demonstrated increased pack years, cerebrovascular events, anticoagulation, elevated creatinine and CA 19-9 as preoperative risk factors. In multivariate analysis, antihypertensive medication (AHT; OR 2.46; 95% CI 1.57 – 3.87; p = 0.05), operation time (OR 1.01; 95% CI 1.00 – 1.01; p = 0.03), extended LAD (OR 5.46; 95% CI 2.77 – 10.75; p = 0.01) and severe PPH (OR 4.01; 95% CI 2.07 – 7.76; p = 0.04) are significant risk factors for longer ICU stay.

Discussion Patients with cardiovascular risk factors and elevated preoperative creatinine level are at greater risk for a prolonged ICU stay. Risk and benefit of an extended LAD should be weighed during the operation. Median duration on ICU/IMC after PD is one day or less for patients without risk factors. Whether routine monitoring in the ICU/IMC after PD is necessary must be clarified in further studies.

Key words

pancreatic surgery - intensive medicine - abdominal surgery

Publication History

Article published online:
12 October 2020

• References/Literatur

• 1 Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987; 206: 358
• 2 Glenn F, Thorbjarnarson B. Carcinoma of the Pancreas. Ann Surg 1964; 159: 945-958
• 3 Keck T, Wellner UF, Bahra M. et al. Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial. Ann Surg 2016; 263: 440-449 doi:10.1097/sla.0000000000001240
• 4 Nimptsch U, Krautz C, Weber GF. et al. Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated. Ann Surg 2016; 264: 1082-1090 doi:10.1097/sla.0000000000001693
• 5 Chen BP, Chen M, Bennett S. et al. Systematic Review and Meta-analysis of Restrictive Perioperative Fluid Management in Pancreaticoduodenectomy. World J Surg 2018; 42: 2938-2950 doi:10.1007/s00268-018-4545-6
• 6 Bentrem DJ, Yeh JJ, Brennan MF. et al. Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy. J Gastrointest Surg 2005; 9: 1307-1312 doi:10.1016/j.gassur.2005.09.010
• 7 Welsch T, Degrate L, Zschabitz S. et al. The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Langenbecks Arch Surg 2011; 396: 353-362 doi:10.1007/s00423-010-0629-y
• 8 Dasta JF, McLaughlin TP, Mody SH. et al. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005; 33: 1266-1271
• 9 Martin J, Neurohr C, Bauer M. et al. [Cost of intensive care in a German hospital: cost-unit accounting based on the InEK matrix]. Anaesthesist 2008; 57: 505-512 doi:10.1007/s00101-008-1353-7
• 10 Bassi C, Dervenis C, Butturini G. et al. Postoperative pancreatic fistula (POPF): an international study group (ISGPF) definition. Surgery 2005; 138: 8-13 doi:10.1016/j.surg.2005.05.001
• 11 Wente MN, Bassi C, Dervenis C. et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142: 761-768 doi:10.1016/j.surg.2007.05.005
• 12 Wente MN, Veit JA, Bassi C. et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007; 142: 20-25 doi:10.1016/j.surg.2007.02.001
• 13 Wellner U, Makowiec F, Fischer E. et al. Reduced postoperative pancreatic fistula rate after pancreatogastrostomy versus pancreaticojejunostomy. J Gastrointest Surg 2009; 13: 745-751 doi:10.1007/s11605-008-0763-9
• 14 Wellner UF, Sick O, Olschewski M. et al. Randomized controlled single-center trial comparing pancreatogastrostomy versus pancreaticojejunostomy after partial pancreatoduodenectomy. J Gastrointest Surg 2012; 16: 1686-1695 doi:10.1007/s11605-012-1940-4
• 15 Wellner UF, Küsters S, Sick O. et al. Hybrid laparoscopic versus open pylorus-preserving pancreatoduodenectomy: retrospective matched case comparison in 80 patients. Langenbecks Arch Surg 2014; 399: 849-856 doi:10.1007/s00423-014-1236-0
• 16 Dasari BV, Pasquali S, Vohra RS. et al. Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials. J Gastrointest Surg 2015; 19: 1725-1732 doi:10.1007/s11605-015-2859-3
• 17 Farnell MB, Aranha GV, Nimura Y. et al. The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 2008; 12: 651-656 doi:10.1007/s11605-007-0451-1
• 18 Farnell MB, Pearson RK, Sarr MG. et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005; 138: 618-628 doi:10.1016/j.surg.2005.06.044
• 19 Orci LA, Meyer J, Combescure C. et al. A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma. HPB (Oxford) 2015; 17: 565-572 doi:10.1111/hpb.12407
• 20 Pedrazzoli S, DiCarlo V, Dionigi R. et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998; 228: 508-517
• 21 Yeo CJ, Cameron JL, Lillemoe KD. et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236: 355-366 doi:10.1097/01.sla.0000027272.08464.0b
• 22 Ravikumar R, Sabin C, Abu Hilal M. et al. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. J Am Coll Surg 2014; 218: 401-411 doi:10.1016/j.jamcollsurg.2013.11.017
• 23 Riediger H, Makowiec F, Fischer E. et al. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 2006; 10: 1106-1115 doi:10.1016/j.gassur.2006.04.002
• 24 Cloyd JM, Ma Y, Morton JM. et al. Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the National Surgical Quality Improvement Program. J Gastrointest Surg 2014; 18: 605-612
• 25 Squires MH, Mehta VV, Fisher SB. et al. Effect of preoperative renal insufficiency on postoperative outcomes after pancreatic resection: a single institution experience of 1,061 consecutive patients. J Am Coll Surg 2014; 218: 92-101 doi:10.1016/j.jamcollsurg.2013.09.012
• 26 Gaber AO, Moore LW, Aloia TA. et al. Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery. Ann Surg 2013; 258: 169-177 doi:10.1097/SLA.0b013e318288e18e
• 27 Ferrone CR, Finkelstein DM, Thayer SP. et al. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol 2006; 24: 2897-2902 doi:10.1200/jco.2005.05.3934
• 28 Casadei R, Ricci C, Lazzarini E. et al. Pancreatic resection in patients 80 years or older: a meta-analysis and systematic review. Pancreas 2014; 43: 1208-1218 doi:10.1097/mpa.0000000000000182
• 29 El Nakeeb A, Hamed H, Shehta A. et al. Impact of obesity on surgical outcomes post-pancreaticoduodenectomy: a case-control study. Int J Surg 2014; 12: 488-493 doi:10.1016/j.ijsu.2014.01.017
• 30 Shamali A, Shelat V, Jaber B. et al. Impact of obesity on short and long term results following a pancreatico-duodenectomy. Int J Surg 2017; 42: 191-196 doi:10.1016/j.ijsu.2017.04.058